C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/437 (2006.01) A61P 31/12 (2006.01) A61P 35/00 (2006.01) C07D 221/00 (2006.01) C07D 235/00 (2006.01)
Patent
CA 2430844
Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and aryl or alkenyl functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.
Cette invention concerne des composés d'imidazoquinoline et de tétrahydroimidazoquinoline comprenant une fonctionnalité éther et aryle ou alcényle en position 1 et qui sont utiles en tant que modificateurs des réponses immunitaires. Les composés et compositions selon l'invention peuvent induire la biosynthèse de diverses cytokines et conviennent bien pour le traitement de diverses pathologies, dont des maladies virales et néoplasiques.
Charles Leslie J.
Dellaria Joseph F.
Heppner Philip D.
Merrill Bryon A.
Mickelson John W.
3m Innovative Properties Company
Robic
LandOfFree
Aryl ether substituted imidazoquinolines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl ether substituted imidazoquinolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl ether substituted imidazoquinolines will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1352233